Nanocan Therapeutics Corp — Form D
Nanocan Therapeutics Corp of NATIONAL HARBOR, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-18. The offering totals $6.5M, of which $5.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-18
- Form: D
- Accession: 0001820532-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $5.1M
- Remaining: $1.4M
- Investors: 41
- Date of first sale: 2022-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-538540
Issuer
- Name: Nanocan Therapeutics Corp
- CIK: 0001820532
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 137 NATIONAL PLZ STE 300, NATIONAL HARBOR, MD, 20745
- Phone: (202) 258-1591
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Eric C Broyles | Director | NATIONAL HARBOR, MD |
| Jacques P Walker | Director | NATIONAL HARBOR, MD |
| Eric C Broyles | Executive Officer | NATIONAL HARBOR, MD |
| Dave P Krasne | Executive Officer | NATIONAL HARBOR, MD |
| Jacques P Walker | Executive Officer | NATIONAL HARBOR, MD |
| Jacques Walker | Executive Officer | Princeton, NJ |
| Eric Broyles | Director | Princeton, NJ |
| Eric Broyles | Executive Officer | Princeton, NJ |
Other filings by this issuer (1)
More